Exposing Big Pharma's Gross Price Gouging | Troy Rafferty | TMR
November 17, 2023
5,462
405
39
8.13%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Sam Seder Episodes Around November 17, 2023
See what was published immediately before and after this episode.
23:04Now PlayingExposing Big Pharma's Gross Price Gouging | Troy Rafferty | TMR
YouTube Description
as posted by the channelTroy Rafferty then joins to explore the devastating impact of Big Pharma’s price gouging of life-saving insulin medication, tackling the prevalence of diabetes and the central role insulin plays in mitigating its deadly impacts, and the role both manufacturers and pharmaceutical middle-men (called Pharmacy Benefit Managers) play in exponentially pushing up the prices on irreplaceable drugs, before they wrap up with a conversation on the failure of the US government to properly hold these bad actors accountable, and what a single-payer system could do to prevent this from ever happening again.
Watch the Majority Report live MondayFriday at 12 p.m. EST on YouTube OR listen via daily podcast at
#SamSeder #EmmaVigeland #MajorityReport #politics #news #progressive #leftist #democrats #liberal
SUPPORT the show by becoming a member
Download TMR's FREE app
CHECK OUT MORE from the MR crew:
Matt Binder DOOMED
Brandon Sutton DISCOURSE
Emma Vigeland ESVN
Matt Lech LEFT RECKONING
OTHER LINKS:
Image Credit, Images Money
Image has been cropped and color has been altered.
Links & Promotions
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.









